Cargando…
Determination of Potential Drug Candidate Molecules of the Hypericum perforatum for COVID-19 Treatment
The novel human coronavirus was firstly emerged in December 2019 in Wuhan, China, and has spread rapidly around the world. There is no known specific effective treatment of COVID-19. The most commonly used agents against this disease both in Turkey and around the world include chloroquine, hydroxych...
Autores principales: | Yalçın, Serap, Yalçınkaya, Seda, Ercan, Fahriye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921287/ https://www.ncbi.nlm.nih.gov/pubmed/33680715 http://dx.doi.org/10.1007/s40495-021-00254-9 |
Ejemplares similares
-
Ellagic Acid, Kaempferol, and Quercetin from Acacia nilotica: Promising Combined Drug With Multiple Mechanisms of Action
por: Al-Nour, Mosab Yahya, et al.
Publicado: (2019) -
Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach
por: Rolta, Rajan, et al.
Publicado: (2022) -
Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach
por: Rolta, Rajan, et al.
Publicado: (2021) -
Myricetin: a Multifunctional Flavonol in Biomedicine
por: Agraharam, Gopikrishna, et al.
Publicado: (2022) -
In silico detection of inhibitor potential of Passiflora compounds against SARS-Cov-2(Covid-19) main protease by using molecular docking and dynamic analyses
por: Yalçın, Serap, et al.
Publicado: (2021)